EssilorLuxottica (OTCMKTS:ESLOY) Sees Large Volume Increase - Here's Why

Key Points

• Trading volume surged by 115% to 247,246 shares mid-day, with the ADR last trading at $115.1705 versus a prior close of $116.26, a slight intraday decline (~0.1%).
• Brokerages including Kepler Capital Markets and HSBC upgraded EssilorLuxottica to Buy, leaving an average consensus of Buy (2 Strong Buy, 5 Buy, 1 Hold).
• The company has low leverage (debt-to-equity 0.17) but modest liquidity (current ratio 0.99, quick ratio 0.70), and the stock is trading below its 50-day ($128.92) and 200-day ($154.68) moving averages.

Shares of EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY - Get Free Report) saw an uptick in trading volume on Monday . 247,246 shares traded hands during mid-day trading, an increase of 115% from the previous session's volume of 114,866 shares.The stock last traded at $115.1705 and had previously closed at $116.26.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on ESLOY. Kepler Capital Markets raised shares of EssilorLuxottica from a "hold" rating to a "buy" rating in a research note on Thursday, January 15th. HSBC raised shares of EssilorLuxottica from a "hold" rating to a "buy" rating in a research note on Wednesday, January 14th. Two equities research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of "Buy".

EssilorLuxottica Stock Down 0.1%

The company has a debt-to-equity ratio of 0.17, a current ratio of 0.99 and a quick ratio of 0.70. The company's 50 day simple moving average is $128.92 and its 200-day simple moving average is $154.68.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company's product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.